Menu
GeneBe

X-120626654-G-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_001011551.3(C1GALT1C1):c.513C>A(p.His171Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,207,282 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 2 hem., cov: 24)
Exomes 𝑓: 0.000010 ( 0 hom. 5 hem. )

Consequence

C1GALT1C1
NM_001011551.3 missense

Scores

1
6
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.441
Variant links:
Genes affected
C1GALT1C1 (HGNC:24338): (C1GALT1 specific chaperone 1) This gene encodes a type II transmembrane protein that is similar to the core 1 beta1,3-galactosyltransferase 1, which catalyzes the synthesis of the core-1 structure, also known as Thomsen-Friedenreich antigen, on O-linked glycans. This gene product lacks the galactosyltransferase activity itself, but instead acts as a molecular chaperone required for the folding, stability and full activity of the core 1 beta1,3-galactosyltransferase 1. Mutations in this gene have been associated with Tn syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High Hemizygotes in GnomAd at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
C1GALT1C1NM_001011551.3 linkuse as main transcriptc.513C>A p.His171Gln missense_variant 2/2 ENST00000304661.6
C1GALT1C1NM_152692.5 linkuse as main transcriptc.513C>A p.His171Gln missense_variant 3/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
C1GALT1C1ENST00000304661.6 linkuse as main transcriptc.513C>A p.His171Gln missense_variant 2/21 NM_001011551.3 P1
C1GALT1C1ENST00000371313.2 linkuse as main transcriptc.513C>A p.His171Gln missense_variant 3/31 P1

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111939
Hom.:
0
Cov.:
24
AF XY:
0.0000586
AC XY:
2
AN XY:
34131
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000278
AC:
5
AN:
180159
Hom.:
0
AF XY:
0.0000616
AC XY:
4
AN XY:
64923
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000619
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000100
AC:
11
AN:
1095343
Hom.:
0
Cov.:
31
AF XY:
0.0000138
AC XY:
5
AN XY:
361097
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000131
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111939
Hom.:
0
Cov.:
24
AF XY:
0.0000586
AC XY:
2
AN XY:
34131
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000376
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000214
Hom.:
1
Bravo
AF:
0.0000227
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 08, 2023The c.513C>A (p.H171Q) alteration is located in exon 3 (coding exon 1) of the C1GALT1C1 gene. This alteration results from a C to A substitution at nucleotide position 513, causing the histidine (H) at amino acid position 171 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.27
Cadd
Benign
22
Dann
Uncertain
0.98
DEOGEN2
Uncertain
0.44
T;T
FATHMM_MKL
Uncertain
0.83
D
M_CAP
Benign
0.019
T
MetaRNN
Uncertain
0.71
D;D
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.8
L;L
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-5.0
D;D
REVEL
Benign
0.22
Sift
Benign
0.21
T;T
Sift4G
Uncertain
0.054
T;T
Polyphen
0.98
D;D
Vest4
0.54
MutPred
0.45
Loss of catalytic residue at H171 (P = 0.0265);Loss of catalytic residue at H171 (P = 0.0265);
MVP
0.69
MPC
0.39
ClinPred
0.60
D
GERP RS
3.2
Varity_R
0.58
gMVP
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372151456; hg19: chrX-119760509; API